Neurospine Search



  • HOME
  • Sponsor
Platinum Level Gold Level Silver Level Bronze Level

• Neurospine expresses sincere gratitude to our proud corporate supporters.
• Neurospine and Corporate sponsors should follow regulation of Fair Trade Act of Korea.
• Editorial and review activities of Neurospine are strictly independent from corporate supporters.
• Neurospine staff would be happy to discuss with potential corporate supporters in additional partnership prospects.

Please contact:
        Mrs. Gye Soon Ahn
        Department of Neurosurgery, Yonsei University College of Medicine.
        50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
        Tel: +82-2-2228-2158

Platinum Sponsors


Powered by our portfolio of Advanced Surgery products:
    The haemostats trusted to stop the bleeding.
    The sealants clinicians count on to close the wounds.
    The tissue and bone repair solutions surgeons rely on to promote healing.

Because they have confidence that these products will work. With Baxter’s advanced surgery solutions, it’s the details that make a big difference. Driving clinician confidence. Reducing the time patients spend in the OR. Creating efficiencies. Impacting clinical outcomes – and real lives. Across specialties. Throughout health systems. Around the globe. Merging art and science, Together with our clinical partners, we embody hope and empower healing.
Baxter. Advanced Surgery Advancing the art of healing.


Since its establishment in 2004,
GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001.
Furthermore, the CE mark on each product confirms its conformity with all of the legal requirements.
GEONSS always concentrates on our customers and patients with the very high levels of innovation and technical expertise,
providing a wide range of products categorized as 3d cage, peek cage, and Bone & Tissue.

Pfizer Korea

Since its establishment in 1969, Pfizer Korea, a Korean subsidiary of Pfizer, has been providing innovative and excellent products for the realization of 'healthy life together'. Pfizer Korea focuses on pharmaceuticals and vaccines in a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Through this, we contribute to the improvement of the national health and the development of the domestic pharmaceutical industry. In addition, Pfizer Korea, as a responsible corporate citizen, takes the ‘contribution of community development’ as an important value for the company and continues to carry out various social contribution programs.

Gold Sponsors

CG Bio

CG Bio is a total healthcare provider with a goal of enhancing the quality of life by offering range of innovative solutions for the spectrum of spinal disorders. Through extensive research activity, CG Bio is a leading comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, and Growth Factor rh-BMP2. Cell & Growth Factor Biotechnology.


Established in 1945, Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2020.
In addition to its product portfolio, which includes 15 blockbuster products, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners.
In the future, Daewoong will expand its global business with its foreign branches and global partners and become a global healthcare group which contributes to improving the quality of life for people worldwide.


Medtronic, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. The company is committed to transforming healthcare especially in the areas of Therapy Innovation; providing a spectrum of offerings aimed at improving both economic and patient outcomes, Globalization; Adapting our thinking to address healthcare access challenges in both developed and developing countries, and Economic Value; Thinking more holistically about the care continuum, and how we can lead the creation of value-based healthcare solutions.

Medtronic’s business consists of four groups; Cardiac & Vascular Group, Diabetes Group, Minimally Invasive Therapies Group and Restorative Therapies Group. The Cardiac & Vascular Group products include Implantable devices like pacemakers, ICDs to correct heart rhythm issues, drug-coated balloons to open blocked arteries and so on. Diabetes Group focuses on computerized insulin pumps, injection ports and mobile monitoring. Minimally Invasive Therapies Group offers solutions that enable earlier diagnosis, better treatment, faster complication-free recovery, and enhanced patient outcomes through less-invasive treatments. Restorative Therapies Group provides Implantable deep-brain stimulation systems, revascularization devices and other pain therapies.

Silver Sponsors

Lilly Korea

Lilly Korea is a pharmaceutical company specializing in treatments that is 100 percent owned by Eli Lilly, a world-class research and development-oriented pharmaceutical company, and was established here in 1998 under the predecessor of Daewoong Pharmaceutical Co., a joint venture between Eli Lilly Co. and Daewoong Pharmaceutical Co. Lilly Korea, which has been growing steadily since its establishment, has provided innovative advanced drugs for the treatment of diabetes, cancer, osteoporosis and pain, autoimmune diseases, male health, and mental nervous system diseases, and successfully introduced innovative new medicines to the domestic market.


Since its establishment in 1997, Cellumed Co.,Ltd is a bio company that manufactures and supplies medical devices, biologics, and cosmeceuticals under the corporate philosophy of respecting human beings.

We succeeded in developing and mass-producing animal(CHO cell)-derived bone formation protein rhBMP2 for the first time in Asia and the second in the world. Our own Rafugen ™ DBM Gel that Cellumed developed has obtained FDA approval in 2018, thus our biotechnology is also well acknowledged overseas. In addition to distributing allografts, it is leading tissue bank in Korea that has the technology to directly process and sterilize human tissues, and is managed by the Ministry of Food and Drug Safety (MFDS) every year to handle safe human tissues.
In order to contribute to human health, Cellumed spares no investments in research and development, such as medical devices and biotechnology, and strives to provide the best products and services.


DePuy Synthes Spine is the second largest spine company in the world with one of the most comprehensive portfolios of spinal care solutions that address key areas including thoracolumbar, cervical, aging spine, interbody fusion, and MIS surgery. The company's leading solutions include EXPEDIUM VERSE® Spinal System to treat spinal conditions ranging from scoliosis to degenerative disc disease; the CONCORDE® Systems & SYNCAGE® Evolution System to treat the Lumbar spine; the VIPER 2 and VIPER 3D™ System for MISS; SYNAPSE™ System and the ZERO-P® Family of Implants to treat the cervical spine and finally, a suite of biomaterial solutions like DBX.


Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.

Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.


The sales of Hans Biomed Co. have grown around 25% for the last 5 years in a row, holding a stable financial position. In addition, we have 7 overseas subsidiaries and local branch offices around the world to expand business in the world. Starting R&D investment in new medical treatments and technology relate to regenerative medicine as well as tissue engineering, Hans Biomed has prepared itself for a new challenge for better health of humankind.

Bronze Sponsors

Hanmi Pharm. Co.,Ltd

Creativity & Innovation
Hanmi jumps up to be a global leading pharmaceutical company with development of new biologics, new chemical entities, and innovative new drugs. The slogan of Hanmi is 'creation and challenge' as Hanmi tries to make new ways for the domestic pharmaceutical market.

No.1 R&D
Hanmi focuses on developing new drug projects such as LAPSCOVERY and anticancer drugs targeting the global market. The synergy effect of research and development is expected from our “Open Innovation” strategy, which opened other excellent R&D capabilities.

Editorial Office
Department of Neurosurgery, Yonsei University College of Medicine
50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-2158  E-mail:
The Korean Spinal Neurosurgery Society
#407, Dong-A Villate 2nd Town, 350 Seocho-daero, Seocho-gu, Seoul 06631, Korea
Tel: +82-2-585-5455  Fax: +82-2-2-523-6812  E-mail:
Business License No.: 209-82-62443

Copyright © The Korean Spinal Neurosurgery Society. All rights reserved.

Developed in M2PI

Close layer
prev next